← All organizations

Moberg Pharma AB

For profitWebsite ↗

Also known as: Moberg Pharma AB | MOBERG PHARMA NORTH | Moberg Pharma, Sweden

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 9, 2022

Timeline

2000s

Jan 7, 2004
ibuprofen— NDA Secondary Org
Jun 1, 2006
Moberg Pharma AB— Founded

Drugs by trial phase (12 distinct, 14 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

sodium chloride

Indications

Studied for

Marketed drugs (1)

ibuprofen

Recent trials (14)

NCT05279846Lead sponsorPhase 3May 9, 2022
NCT03244280Lead sponsorPhase 1Dec 16, 2017
NCT06369675Lead sponsorPhase 1Oct 19, 2017
NCT06369727Lead sponsorPhase 1Oct 15, 2017
NCT02866032Lead sponsorPhase 3Sep 1, 2016
NCT02859519Lead sponsorPhase 3Sep 1, 2016
NCT02252926CollaboratorPhase 2Sep 1, 2014
NCT01814020Lead sponsorPhase 2Dec 1, 2012
NCT01611480Lead sponsorPhase 2Jun 1, 2012
NCT01567683Lead sponsorPhase 1Mar 29, 2012
NCT01246518Lead sponsorPhase 2Dec 1, 2010
NCT00863005Lead sponsorPhase 1/Phase 2Mar 12, 2009
NCT01137331Lead sponsorPhase 3Feb 1, 2008
NCT01137630Lead sponsorPhase 2/Phase 3Feb 1, 2007

Details

Founded: Bromma, SE Jun 1, 2006
Last known activity: May 9, 2022